Innovations In Clinical Neuroscience

JAN-FEB 2018

A peer-reviewed, evidence-based journal for clinicians in the field of neuroscience

Issue link: https://innovationscns.epubxp.com/i/935919

Contents of this Issue

Navigation

Page 23 of 53

C A S E S E R I E S 24 ICNS Innovations in Clinical Neuroscience • January–February 2018 • Volume 15 • Number 1–2 TABLE 1. Clinical details of the patients who underwent ECT CHARACTERISTICS PATIENT A PATIENT B PATIENT C PATIENT D PATIENT E PATIENT F Age 56 years 62 years 70 years 69 years 52 years 60 years Sex M M M F F M Psychiatric diagnosis (as per ICD-10) F33.3 F33.3 F32.3 F33.2 F32.3 F33.2 Total duration of psychiatric illness 9 years 8 years 7 months 22 years 18 months 35 years Duration of current depressive episode 3 months 18 months 7 months 5–6 months 18 months 24 months Total duration of Parkinson's disease 9 years 10 years 14 years 2–3 months 5 years 3 months Other comorbidities Bullous Pemphigoid, benign prostatic, hyperplasia Hearing impairment None Hypertension None Hypertension, diabetes mellitus Antidepressants at baseline Mirtazepine Venlafaxine Escitalopram Venlafaxine Venlafaxine Bupropion Antiparkinsonian medication at baseline Levodopa, carbidopa, entacapone trihexyphenidyl, baclofen, rasageline Levodopa, carbidopa, entacapone, pramipexole Levodopa, carbidopa, ropinirole, selegiline trixhexyphenidyl Levodopa, carbidopa Levodopa, carbidopa None Other medications at baseline Tamsulosin None None Amlodipine None Hydrochlorthiazide, losartan, aspirin, metformin HDRS at baseline 28 26 (BDI) 21 n/a 27 37 GDS at baseline - 25 12 29 n/a n/a UPDRS at baseline 58 61 27 48 38 44 MMSE at baseline 25 27 26 25 8 24 ECT- energy delivered at first ECT n/a 27J 24J 43J 25J 19J ECT- mean energy delivered during the ECT course n/a 31.5J 67.2J 52J 27.7J 29.3J Total number of ECTs 7 7 9 13 15 9 HDRS at the end of ECT 9 6 (BDI) 2 n/a 12 11 GDS at the end of ECT n/a 10 3 12 n/a n/a UPDRS at the end of ECT 20 20 10 20 23 16 MMSE at the end of ECT 27 29 29 21 13 26 Delirium during the course of ECT None None None None None None Any other ECT-related complications None None None None None None Abbreviations: ICD-10, International Classification of Diseases, 10th Revision; HDRS, Hamilton Depression Rating Scale; BDI, Beck's Depression Inventory; GDS, Global Deterioration Scale; UPDRS, Unified Parkinson Disease Rating Scale; MMSE, Mini-mental State Examination; ECT, electroconvulsive therapy; n/a: not available

Articles in this issue

Archives of this issue

view archives of Innovations In Clinical Neuroscience - JAN-FEB 2018